| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $3.89M | $11.24M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $39.16M | $40.98M | $39.66M | $85.60M | $141.49M |
| R&D | $18.78M | $22.09M | $18.59M | $17.65M | $11.52M |
| SG&A | $23.63M | $18.34M | $20.57M | $65.03M | $105.06M |
| Operating Income | -$39.16M | -$40.98M | -$39.66M | -$81.71M | -$130.25M |
| Interest Expense | – | – | $5.81M | $7.27M | $8.38M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$26.98M | -$38.51M | -$42.20M | -$44.82M | -$142.60M |
| EPS (basic) | -3.3100 | -10.1500 | -17.3500 | -29.4800 | -2.1900 |
| EPS (diluted) | -3.3100 | -10.1500 | -17.3500 | -29.4800 | -2.1900 |
| Shares (diluted) | $8.15M | $3.80M | $2.43M | $1.52M | $65.20M |